SEC 13F Intelligence

Spouting Rock Asset Management, LLC / RXRX

Spouting Rock Asset Management, LLC’s Recursion Pharmaceuticals In Position

Does Spouting Rock Asset Management, LLC own Recursion Pharmaceuticals In (RXRX)? Not currently — the last reported position was 90.2K shares worth $2M in Q4 2021; the fund’s latest 13F (Q4 2023) no longer reports it.

Position Value
$2M
Q4 2021
Shares
90.2K
% of Portfolio
+1.21%
Quarters Held
2
position exited

Position History RXRX

Reported value by quarter
Q3 ’21: $1MQ3 ’21Q4 ’21: $2MQ4 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q4 202190.2K$2M+1.21%
Q3 202152.9K$1M+0.61%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Spouting Rock Asset Management, LLC’s full portfolio or all institutional holders of RXRX.